Clinical Trial Update: Gemcitabine Plus Paclitaxel in Treating Patients With Advanced Non-small Cell Lung Cancer or Other Solid Tumor [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update describes a Phase 1/2 study of gemcitabine plus paclitaxel in advanced non-small cell lung cancer and other solid tumors, which has b…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Gemzar (gemcitabine)
• Taxol (paclitaxel)

Snippet

Sponsor: University of Alabama at Birmingham | Conditions: Lung Cancer | Phase 1, Phase 2 | Status: TERMINATED